Mifepristone and Misoprostol for the management of placenta accreta – a new alternative approach

Morgan, M.; Atalla, Rami

doi:10.1111/j.1471-0528.2009.02159.x

Cited by 21 publications

(11 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The placental tissues may be passed at a later date, but in other cases the placenta appears to resorb, without any noticeable tissue expulsion. Mifepristone and misoprostol has been successfully used for the expulsion of a retained placenta accreta in a recent report of two cases (26), however this requires further evaluation and may not be appropriate in cases of placenta increta or percreta.…”

Section: Managementmentioning

confidence: 99%

The morbidly adherent placenta: an overview of management options

Doumouchtsis

Arulkumaran

2010

Acta Obstet Gynecol Scand

100

View full text Add to dashboard Cite

Morbidly adherent placenta is often associated with severe maternal morbidity. An increased incidence over the recent years may be secondary to the increased cesarean section rates. Identification of patients with risk factors antenatally is essential for the early diagnosis and management. Diagnosis can be achieved by ultrasound or MRI in the majority of cases. Management aims to ensure a safe delivery of the fetus, alongside measures of prevention or effective management of postpartum hemorrhage. When a hysterectomy is performed, a multidisciplinary team with surgical expertise and facilities for transfusion and further interventions including arterial ligation and interventional radiology should be available. The options for conservative treatments offer the potential to preserve fertility but further research with prospective evaluation of the different approaches is necessary.

show abstract

Section: Managementmentioning

confidence: 99%

The morbidly adherent placenta: an overview of management options

Doumouchtsis

Arulkumaran

2010

Acta Obstet Gynecol Scand

100

View full text Add to dashboard Cite

show abstract

“…1 The authors did not mention the one-step surgical approach that we have described as an alternative conservative treatment. 2 In summary, this operation involves extensive retrovesical and parametrial dissection and selective vascular ligature.…”

Section: Sirmentioning

confidence: 97%

“…Sir, We read with great interest the letter submitted by Palacios-Jaraquemada and Fiorillo 1 . Our impression is that the authors have misunderstood the aim of our new technique, which is a non-surgical, minimal interventional approach.…”

Section: Authors' Replymentioning

confidence: 99%

Conservative therapy in placenta accreta: unexpected problems after drug‐induced uterine contractions

Palacios-Jaraquemada

Fiorillo

2009

BJOG

View full text Add to dashboard Cite

“…Subsequent interventions include expectant management (65), uterine artery embolization (UAE) followed by expectant management (66), and adjuvant medical treatment. The latter includes adjuvant MTX treatment (67,68), novel adjuvant treatment by gonadotropin releasing hormone analogues (69), and mifepristone and misoprostol (70).…”

Section: Managementmentioning

confidence: 99%

Abnormal Placental Invasion—a Novel Approach to Treatment

Ophir¹,

Singer-Jordan²,

Odeh³

et al. 2009

Obstetrical &Amp; Gynecological Survey

View full text Add to dashboard Cite

The incidence of abnormal placental invasion has increased 10-fold in the past 50 years, reflecting the increased number of cesarean sections performed. Management relies on accurate early diagnosis with appropriate perioperative multidisciplinary planning to anticipate and avoid massive obstetric hemorrhage at delivery. Women at risk should plan to deliver at an institution with appropriate expertise and resources for managing this condition. We report a case of placenta increta management comprising preoperative placement of a pelvic artery balloon catheter, prophylactic balloon occlusion after delivery of the fetus, and embolization-assisted resection of the invaded uterine wall. We review incidence, methods of prenatal diagnosis, risk factors, and management of abnormally invasive placenta.

show abstract

Mifepristone and Misoprostol for the management of placenta accreta – a new alternative approach

Cited by 21 publications

References 6 publications

The morbidly adherent placenta: an overview of management options

The morbidly adherent placenta: an overview of management options

Conservative therapy in placenta accreta: unexpected problems after drug‐induced uterine contractions

Abnormal Placental Invasion—a Novel Approach to Treatment

Contact Info

Product

Resources

About